Fountzilas, Elena <br/><br/>
A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without intravenous bevacizumab, in patients with advanced cancer and predominant liver involvement.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  11 2018 
 - 877-885 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-018-3680-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Bevacizumab--administration & dosage<br/>Capecitabine--administration & dosage<br/>Female<br/>Hepatic Artery<br/>Humans<br/>Infusions, Intra-Arterial<br/>Injections, Intravenous<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Neoplasm Invasiveness<br/>Oxaliplatin--administration & dosage<br/>Treatment Outcome